Voyager Therapeutics
Latest round
- Series B
Last raised
- Apr 2015
Total raised
- $85M
Investors
- 5
About Voyager Therapeutics
Founded in 2014, Voyager Therapeutics is based in Cambridge, US, and focuses on developing genetic medicines to treat neurological disorders.Voyager Therapeutics is focused on the development of innovative gene therapies aimed at treating a range of neurological diseases. The company’s primary product offerings include genetic medicines targeting Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and other central nervous system disorders. These therapies utilize the TRACER™ (Translationally-Optimized AAV Capsid Engineering) platform, which enables the creation of novel AAV capsids designed for efficient delivery across the blood-brain barrier. The end users of these therapies are primarily patients suffering from these debilitating conditions, while the company collaborates with various healthcare providers and research institutions to bring these products to market.59 mn. The company generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research organizations, which include milestone payments and royalties from product sales. The company aims to launch new products aimed at treating various neurological disorders in the coming years. Additionally, Voyager Therapeutics is actively exploring opportunities to expand into new geographic markets, particularly targeting Europe and Asia, with initiatives expected to commence within the next 2 years.
Who invested in Voyager Therapeutics
5 investors across 2 rounds
See all investors in Voyager Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Voyager Therapeutics
Who invested in Voyager Therapeutics?
Voyager Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Voyager Therapeutics raised?
Voyager Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Voyager Therapeutics last raise money?
Voyager Therapeutics's most recent round on record is a Series B, in Apr 2015.
What does Voyager Therapeutics do?
Founded in 2014, Voyager Therapeutics is based in Cambridge, US, and focuses on developing genetic medicines to treat neurological disorders.
Where is Voyager Therapeutics headquartered?
Voyager Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Voyager Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Voyager Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Voyager Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.